The Therapeutic Effect and Mechanism of Lactobacillus gardneri on Nonalcoholic Fatty Liver Disease
Journal of Microbiology and Biotechnology · 2025
DOI: 10.4014/jmb.2501.01051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Keyan Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu, 225001, P.R. China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Probiotics, Lactobacillus gasseri. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This study aimed to investigate the effect of Lactobacillus gasseri SBT2055 (LG2055) on non-alcoholic fatty liver disease (NAFLD). Mice were fed with high-fat diet (HFD) to establish NAFLD animal model. HFD mice were administrated with LG2055 gavage to explore the role of LG2055 on NAFLD. This study revealed that LG2055 gavage decreased serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), and triglyceride (TG), reduced lipid accumulation in liver tissue, promoted the expression of intestinal mucosal proteins mucin 2 (MUC2), defensin alpha 1 (DEFA1), and defensin alpha 4 (DEFA4), inhibited the levels of pro-inflammatory factors tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6, and increased the levels of anti-inflammatory factors IL-10 and immunoglobulin (Ig)A, IgG, and IgM. LG2055 decreased the abundance of Verrucomicrobota, Akkermansiaceae and Akkermansia while increased the abundance of Bacteroidota, Actinobacterota and Muribaculaceae. These findings implied that LG2055 alleviate liver damage caused by NAFLD by reducing hepatic lipid accumulation and gut homeostasis and regulating gut microbiota to inhibit intestinal inflammation, and increase immune regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu, 225001, P.R. China.
- Department of Pharmacology, School of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, P.R. China.
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, Jiangsu, 225001, P.R. China.
- Reproductive center, The First People's Hospital of Huai'an, Huai'an, Jiangsu, 223001, P.R. China.
- Orthopedics department, Huai'an 82 Hospital, Huai'an, Jiangsu, 223001, P.R. China.
- Department of Gastroenterology, Northern Jiangsu People's Hospital, Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu, 225009, P.R. China.
Zitieren
APA
Zhu, K., Xiang, J., Lu, F., Wang, J., Zhang, Y., Feng, H., & Xiang, X. (2025). The Therapeutic Effect and Mechanism of Lactobacillus gardneri on Nonalcoholic Fatty Liver Disease. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2501.01051
Vancouver
Zhu K, Xiang J, Lu F, Wang J, Zhang Y, Feng H, et al. The Therapeutic Effect and Mechanism of Lactobacillus gardneri on Nonalcoholic Fatty Liver Disease. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2501.01051
BibTeX
@article{Zhu2025,
author = {Zhu, Keyan and Xiang, Jie and Lu, Fengqin and Wang, Jiabo and Zhang, Yu and Feng, Haibo and Xiang, Xiaoxing},
title = {The Therapeutic Effect and Mechanism of Lactobacillus gardneri on Nonalcoholic Fatty Liver Disease},
journal = {Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.4014/jmb.2501.01051}
}
EUVIMED